Patents by Inventor Eric H. WESTIN

Eric H. WESTIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
    Patent number: 11760803
    Abstract: The invention provides, inter alia, methods of reducing gastrointestinal immune related adverse events, such as colitis and diarrhea, in subjects undergoing an immune treatment, such as an immune oncology treatment, such as anti-CTLA4 antibody and anti-PD-1 antibody combination treatment for melanoma. In certain aspects, the methods encompass administering a therapeutically effective amount of a polypeptide that inhibits MAdCAM-integrin binding, such as an anti-?4?7 integrin antibody, such vedolizumab or a related antibody.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: September 19, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Rachael L. Brake, Eric H. Westin
  • METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS IN IMMUNE ONCOLOGY TREATMENTS
    Publication number: 20190040140
    Abstract: The invention provides, inter alia, methods of reducing gastrointestinal immunerelated adverse events, such as colitis and diarrhea, in subjects undergoing an immune treatment, such as an immune oncology treatment, such as anti-CTLA4 antibody and anti-PD-1 antibody combination treatment for melanoma. In certain aspects, the methods encompass administering a therapeutically effective amount of a polypeptide that inhibits MAdCAM-integrin binding, such as an anti-?4?7 integrin antibody, such vedolizumab or a related antibody.
    Type: Application
    Filed: March 24, 2017
    Publication date: February 7, 2019
    Inventors: Rachael L. Brake, Eric H. WESTIN